¿¬¼ö°­ÁÂ
2022³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ Expert Meeting : 2022-06-04
2022³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ Expert Meeting : 2022-06-04
±³À°ÀÏÀÚ : 2022-06-04
±³À°Àå¼Ò : AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ)  
±³À°ÁÖÁ¦ : 2022³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ Expert Meeting
ÁÖÃÖ±â°ü : ´ëÇѳ²¼º°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺñ´¢È£¸£¸ó¿¬±¸ÇÐȸ  
´ã´çÀÚ : ¹Ú¼ºÀº
¿¬¶ôó : 02-6956-7989  
À̸ÞÀÏ : gaonpco@gaonpco.com      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 30¸í
Èñ¸ÁÆòÁ¡ : 2Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 2 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 20,000¿ø      
ºñ°í Àü¹®ÀÇ 20,000¿ø / Àü°øÀÇ,¿¬±¸¿ø,Çлý 10,000¿ø / ÇöÀåµî·Ï ¾øÀ½      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 09:00~09:15 Urological support for male pituitary adenoma  À̵¿¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 09:15~09:30 Preserving fertility in the treatment of hypogonadism  ¹Ú¹Î±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 09:30~09:45 Experience of testosterone nasal gel in real practice  ½ÅÀ¯¼·(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 09:45~10:00 Lifestyle modification and testosterone  Á¤È£¼®(Àü³²ÀÇ´ë) 
Åä·Ð 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 10:00~10:10 Panel discussion  ¼Õȯö(¼­¿ïÀǾÖ) 
È޽Ġ06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 10:10~10:30 Coffee break  () 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 10:30~10:45 Hormonal approach to male contraception  ±èµ¿¼®(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 10:45~11:00 Post-finasteride syndrome: is it real and clinically relevant?  Á¶¹Îö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 11:00~11:15 The role of testosterone in urethral reconstructive surgery  ¾È¼øÅÂ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 11:15~11:30 Testosterone¡¯s role in COVID-19  ±è¼öÁø(ÇѸ²ÀÇ´ë) 
Åä·Ð 06-04 AstiÈ£ÅÚ ºÎ»ê ±×·£µåº¼·ë (22Ãþ) 11:30~11:40 Panel discussion  ·ùÁö°£(ÀÎÇÏÀÇ´ë) 
  • ÃßõÇϱâ
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù.
¡å
ÀÛ¼ºÀÚ   ºñ¹Ð¹øÈ£
 
¿¬¼ö°­Á ÁÖ°£º£½ºÆ®
Á¦¸ñ

[¼­¿ï] 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ÀÏ¿ø¿ª»ç Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ ±³À°ÁÖÁ¦ : 2024 ½ÉÀå»öÀü¿¬±¸È¸ ½ÉÆ÷Áö¿òÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,085 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­Á : 2024-03-09

±³À°ÀÏÀÚ : 2024-03-09 ±³À°Àå¼Ò : (¿Â¶óÀÎ) ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024³â Á¦5ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,055 , ´ñ±Û¼ö : 0

[¼­¿ï] Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialysis Vascular Access) : 2024-03-31

±³À°ÀÏÀÚ : 2024-03-31 ±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Á¦26Â÷ °¡Å縯ÀÇ´ë ½ÅÀå³»°ú ¿¬¼ö±³À° (Clinical Topics on Hemodialy

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,097 , ´ñ±Û¼ö : 0

[¼­¿ï] (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-03-30

±³À°ÀÏÀÚ : 2024-03-30 ±³À°Àå¼Ò : ¿Â¶óÀÎ »ýÁß°è ±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)Á¦27Â÷ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­ÁÂÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ ´ã´çÀÚ : °û¼ÖÀÌ ¿¬¶ôó : 02-71

Ãßõ¼ö : 0 , Á¶È¸¼ö : 7,184 , ´ñ±Û¼ö : 0

[¼­¿ï] ´ëÇÑÁ¶Çöº´ÇÐȸ Treatment and management of symptoms and physical health in schizophrenia : 2024-04-2..

±³À°ÀÏÀÚ : 2024-04-26 ±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ±³À°ÁÖÁ¦ : Treatment and management of symptoms and physical health i

Ãßõ¼ö : 0 , Á¶È¸¼ö : 6,786 , ´ñ±Û¼ö : 0